A 35-year-old man presents with acute onset of proptosis, chemosis, ophthalmoplegia, and fever following sinusitis. Orbital cellulitis is suspected. What is the drug of choice for empirical treatment?

Explanation

## Orbital Cellulitis: Empirical Antibiotic Choice ### Clinical Context Orbital cellulitis is a medical emergency requiring immediate broad-spectrum IV antibiotics. The condition typically arises from contiguous spread of infection (paranasal sinusitis, dacryocystitis) or haematogenous seeding. ### Microbiology & Empirical Coverage Common causative organisms include: - **Gram-positive cocci:** *Staphylococcus aureus* (including MRSA in some regions), *Streptococcus pneumoniae* - **Gram-negative rods:** *Haemophilus influenzae* (type b and non-typeable), *Klebsiella*, *Proteus* - **Anaerobes:** when associated with sinusitis or odontogenic sources **Key Point:** Empirical therapy must cover both gram-positive and gram-negative organisms, including *S. aureus*, while awaiting culture results. ### Rationale for Ceftriaxone + Vancomycin | Drug | Spectrum | Rationale | |------|----------|----------| | **Ceftriaxone** (3rd-gen cephalosporin) | Gram-positive (non-MRSA), gram-negative, good CNS penetration | Covers *H. influenzae*, *S. pneumoniae*, *E. coli*, *Klebsiella* | | **Vancomycin** | Gram-positive including MRSA, excellent for resistant *S. aureus* | Covers MRSA and penicillin-resistant *S. pneumoniae* | | **Combined** | Synergistic broad spectrum | Gold standard empirical regimen | **High-Yield:** The combination of a 3rd-generation cephalosporin (ceftriaxone or cefotaxime) + vancomycin is the standard empirical regimen for orbital cellulitis in most guidelines, including American Academy of Ophthalmology and Harrison's. ### Dosing in Orbital Cellulitis - **Ceftriaxone:** 1–2 g IV every 12 hours - **Vancomycin:** 15–20 mg/kg IV every 8–12 hours (target trough 15–20 μg/mL) **Clinical Pearl:** Once culture and sensitivities are available, therapy can be narrowed. If *S. aureus* (non-MRSA) is isolated, ceftriaxone monotherapy may suffice; if MRSA is confirmed, vancomycin or linezolid is continued. ### Adjunctive Management - IV fluids and electrolyte correction - Imaging: CT or MRI orbits to assess for abscess formation - Drainage of primary source (e.g., paranasal sinus drainage) if indicated - Corticosteroids (controversial; may be considered in severe cases with significant orbital edema) **Warning:** Delayed or inadequate treatment risks cavernous sinus thrombosis, vision loss, and mortality.